Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2003;28(2):93-107.
doi: 10.1385/IR:28:2:93.

Langerin/CD207 sheds light on formation of birbeck granules and their possible function in Langerhans cells

Affiliations
Review

Langerin/CD207 sheds light on formation of birbeck granules and their possible function in Langerhans cells

Jenny Valladeau et al. Immunol Res. 2003.

Abstract

Langerhans cells (LCs) are immature dendritic cells of epidermis and epithelia, playing a sentinel role through their specialized function in antigen capture, and their capacity to migrate to secondary lymphoid tissue to initiate specific immunity. A unique feature of LCs is the presence of Birbeck granules (BGs), which are disks of two limiting membranes, separated by leaflets with periodic "zipperlike" striations. The recent identification of Langerin/CD207 has allowed researchers to decipher the mechanism of BG formation and approach an understanding of their function. Langerin is a type II lectin with mannose specificity expressed by LCs in epidermis and epithelia. Remarkably, transfection of Langerin cDNA into fibroblasts creates a dense network of membrane structures with features typical of BGs. Furthermore, mutated and deleted forms of Langerin have been engineered to map the functional domains essential for BG formation. Langerin is a potent LC-specific regulator of membrane superimposition and zippering, representing a key molecule to trace LCs and to probe BG function.

PubMed Disclaimer

References

    1. Nat Rev Immunol. 2002 Feb;2(2):77-84 - PubMed
    1. J Immunol. 2002 Jan 15;168(2):782-92 - PubMed
    1. J Invest Dermatol. 2001 Mar;116(3):401-8 - PubMed
    1. J Exp Med. 1990 Nov 1;172(5):1471-82 - PubMed
    1. J Exp Med. 2001 Oct 1;194(7):1013-20 - PubMed

LinkOut - more resources